| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76420-229-30 | 76420-229 | HUMAN PRESCRIPTION DRUG | Tizanidine | Tizanidine | TABLET | ORAL | 20220707 | N/A | ANDA | ANDA076286 | Asclemed USA, Inc. | TIZANIDINE HYDROCHLORIDE | 4 mg/1 | 30 TABLET in 1 BOTTLE (76420-229-30) |
| 76420-229-60 | 76420-229 | HUMAN PRESCRIPTION DRUG | Tizanidine | Tizanidine | TABLET | ORAL | 20220707 | N/A | ANDA | ANDA076286 | Asclemed USA, Inc. | TIZANIDINE HYDROCHLORIDE | 4 mg/1 | 60 TABLET in 1 BOTTLE (76420-229-60) |
| 76420-229-90 | 76420-229 | HUMAN PRESCRIPTION DRUG | Tizanidine | Tizanidine | TABLET | ORAL | 20220707 | N/A | ANDA | ANDA076286 | Asclemed USA, Inc. | TIZANIDINE HYDROCHLORIDE | 4 mg/1 | 90 TABLET in 1 BOTTLE (76420-229-90) |
| 76420-228-18 | 76420-228 | HUMAN PRESCRIPTION DRUG | Tizanidine | Tizanidine | TABLET | ORAL | 20231030 | N/A | ANDA | ANDA076286 | Asclemed USA, Inc. | TIZANIDINE HYDROCHLORIDE | 2 mg/1 | 180 TABLET in 1 BOTTLE (76420-228-18) |
| 76420-228-30 | 76420-228 | HUMAN PRESCRIPTION DRUG | Tizanidine | Tizanidine | TABLET | ORAL | 20220707 | N/A | ANDA | ANDA076286 | Asclemed USA, Inc. | TIZANIDINE HYDROCHLORIDE | 2 mg/1 | 30 TABLET in 1 BOTTLE (76420-228-30) |
| 76420-228-10 | 76420-228 | HUMAN PRESCRIPTION DRUG | Tizanidine | Tizanidine | TABLET | ORAL | 20240109 | N/A | ANDA | ANDA076286 | Asclemed USA, Inc. | TIZANIDINE HYDROCHLORIDE | 2 mg/1 | 10 TABLET in 1 BOTTLE (76420-228-10) |